Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Does Metformin Reduce Cancer Risks? Methodologic Considerations
Asieh Golozar
, Shuiqing Liu
, Joeseph A. Lin
,
Kimberly Peairs
,
Hsin Chieh Yeh
Bloomberg School of Public Health
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Does Metformin Reduce Cancer Risks? Methodologic Considerations'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Risk
100%
Metformin
100%
In Cancer
14%
Drug Use
14%
Randomized Clinical Trial
14%
Pre-diabetes (pre-DM)
14%
Drug Effects
14%
Electronic Health Records
14%
Administrative Database
14%
Methodological Shortcomings
14%
Analytical Techniques
14%
Motivation
14%
Substantial Burden
14%
Methodological Flaws
14%
Methodological Issues
14%
Diabetes Burden
14%
Cancer Burden
14%
Targeting Strategies
14%
Time Bias
14%
Confounding by Indication
14%
Valid Data
14%
Bias-free
14%
User Bias
14%
Accurate Assessment
14%
Proposed Strategy
14%
Erroneous Results
14%
Metformin Use
14%
Mathematics
Confounders
100%
Confounding
100%
Data Source
100%
Complete Information
100%
Computer Science
Data Source
100%
Electronic Medical Record
100%
Methodological Issue
100%
Nursing and Health Professions
Metformin
100%
Malignant Neoplasm
33%
Drug Use
16%
Electronic Medical Record
16%
Diseases
16%
Clinical Trial
16%
Psychology
Metformin
100%
Study Design
33%
Clinical Trial
16%
Social Sciences
Cancer
100%
Diseases
11%
Drug Use
11%
Clinical Trial
11%